Article Sidebar
Main Article Content
Abstract
ésumé :
OBJECTIFSLa symptomatologie du bas appareil urinaire [SBAU] a fait l’objet de nombreuses études dans beaucoup de pays mais très peu dans notre milieu. Le but de cette étude était d’évaluer la prévalence de la SBAU dans notre milieu ainsi que la pathologie tumorale prostatique associée.MÉTHODES :Ils’agit d’une étude transversale réalisée à l’occasion d’une campagne de dépistage volontaire des tumeurs prostatiques. Les paramètres étudiés étaient l’âge des patients, le statut professionnel, le score IPSS, le score de gêne, le résultat du toucher rectal et le celui des dosages de PSA. Était considéré porteur d’une HBP symptomatique tout patient avec un score IPSS supérieur à 8, un score de gêne supérieur ou égal à 3 et une HBP au toucher rectal. Tous les patients avec un toucher rectal suspect et ou des PSA élevés bénéficiaient d’une biopsie prostatique. Nous avons enfin noté la prise en charge.
RÉSULTATSNous avions recruté 329 patients âgés de 45 à 79 ans [moyenne 56 ans]. La moyenne d’âge des patients porteurs d’une hypertrophie bénigne de la prostate était de 61.6 ans. 181 patients [56.9%] avaient un score IPSS jugée modérée à sévère, 200 patients [60,8%] avaient un score de gêne supérieur à 3. Il y avait une corrélation entre l’IPSS et l’âge, l’IPSS et le score de gêne. 184 patients étaient porteurs d’une HBP dont 118 avaient une HBP symptomatique parmi lesquels 17 avaient été opérés, 66 avaient eu un traitement médical et 35 avaient été perdus de vue. 10 patients avaient un cancer de la prostate.
CONCLUSIONLa SBAU de l‘homme est fréquente dans notre milieu. Elle survient dans une population plus jeune que celle décrite dans la littérature. Peu de patients en parlent à leur Médecin malgré les risques de complications pouvant grever le pronostic vital. Il est par conséquent important d’informer les patients et de sensibiliser les médecins sur la SBAU et les pathologies associées.
OBJECTIVES
The low urinary symptoms have been studied in many countries but very little in our.
The objective of this study was to evaluate the prevalence of the low urinary symptoms and related prostatic tumors associated in our country.
METHODS
This cross sectional study was part of a screening outreach for detection of prostatic tumors. The criteria retained were age, professional status, IPSS score, life’s quality score and results of PSA. The rectal examination was also recorded. The patients with abnormal rectal examination or elevated PSA needed prostatic biopsy with pathological examination. Patients with IPSS score over 8, lie’s quality score from 3, and BPH at the rectal examination were considered symptomatic.
RESULTS
We recruited 329 patients aged from 45 to 79 years [mean 56 years]. The mean age for BHP patients was 61.6. Considering IPSS, 181 patients [56.9%] had moderated to severe score. 200 patients [60.8%] had a life’s quality score from 3 to 6. There were correlation between IPSS score and age, IPSS score and gene score. We had BPH in 184 patients from whom 118 were symptomatic. Among those who were symptomatic, 17 were operated, 66 had medical treatment, and 35 were lost to follow up. We diagnosed prostatic cancer in 10 patients.
CONCLUSION
The low urinary symptoms and BPH associated are frequent in our country. They have tendency to be severe. The population concerned is younger than what is reported in the literature. Few patients talk to their doctors about it instead of complications related to pathologies able to cause death. So it is necessary to inform patients and to sensitise medical Doctors about it.
Article Details
References
- Guess N. A, Benign prostatic hyperplasia: antecedents and natural history. Epidemiol. Rev, 1992: 14, 131.
- 2. Barry M. J, Boyle , Garraway W. M, Fang –Liu G, Guess H. A, O’Leary M. P, Ohishi K. and Tsukamoto T; Epidemiology and natural history of BPH. In: Proceedings of the 2nd International consultation in Benign Prostatic Hyperplasia (BPH). Edited by A.T.K. Cockett, S. Khoury, Y. Aso, C. Chatelain, L. Denis, K. Griffitho and G.P. Murphy. Scientific Communication International Ltd, 1993 : pp 19-28.
- 3. Flam T, Montauban V. Groupe Epimix ; Dépistage de l’hypertrophie bénigne de la prostate clinique en médicine générale : Enquête sur 18540 hommes Prog Urol, 2003 ; 13 : 416 – 424.
- 4. Girman C. J: Population based studies of the epidemology of benign prostatic hyperplasia. Br. J. Urol, 1994; 74: 542 –550.
- 5. Tsukamoto T, Kumamoto Y, Masumou N, Guess H. A., Jacobsen J. Steven and Lieber M. M., Prevalence of prostatism in Japanese in community – based study with comparism to similar America study. J. Urol, 1995; 154: 391 – 395.
- 6. Berry S. J, Coffey D. S, Walsh D. C, Ewing L. L: The development of human benign prostatic hyperplasia with age, J. Urol, 1984; 132: 474 –479.
- 7. Sagnier P. P. Richard F, Botto H, Teillac P, Boyle P: Adaptation et validation en langue française des score International des symptômes de l’Hypertrophie bénigne de la prostate. Prog. Urol, 1994 ; 4 :532 –538.
- 8. Cesterling J.E : Benign prostatic hyperplasia : a rview of its histogenesis and natural history. Prostate suppl, 1996 ; 6 :67 – 73.
- 9. Mac Farlone G, Richard F, Botto H, Teillac P, Boyle P: Results of an epidemiologic survey using a modified American Urological Association Symptom index for benign prostatic hyperplasia in France. J. Urol., 1994; 151 : 1266 – 1270.
- 10. Garaway W.M, Collins G. N, Lee R. J: High prevalence of benign prostatic hypertrophy in the community . Lancer 1991; 338 :469 – 471.
- 11. Richard F, Luckas B, Jardin A, Iansony, Cheret Meason M, Gange R. J.C, Navratyl H. Résultats d’une enquête épidémiologique mené chez des hommes âge de 50 à 80 ans étudiant les trouble mictionnels qualifi de vie et fonction sexuelle Prog. Urol, 2001 ; 11 : 250 – 283.
- 12. Garaway W. M, Russel E.B.A.W, Lea R. J., Collino G. B, Hetir M, Roger A. C. N, Simpson R. J: Impart of previously unrecognised benign prostatic hyperplasia on the daily activites of middle – aged and elderly men. Br. J. Gen. Proet, 1993, 43 : 318 –321.
- 13. Chute C. G, Panser L.A, Girman C. J, Vesterling J.E, Guess H. A, Jacobson S. J, Lieber H. R : The prevalence of prostatism : a population based survey of urinary symptoms. J. Urol, 1993; 150 : 85 -88
- 14. Berges R. R, Pientka L, Hafner K, Senge T, Jonas V : male lower urinary tract symptoms and related health care seeking in Germany. Eur. Urol, 2001; 39 : 682 –687.
- 15. Hunter D. J, Beria Unamuno A, Martin – Gordo A, : Prevevalence of urinary symptom and other urological conditions in Spanish men 50 years or older. J. Urol, 1996; 155; 1965 – 1970.
- 16. Norman R. W, Nickel J. C, Fish D, Pickett S. N, “Prostate related symptoms“ in Canadian men 50 years of age or older. Prevalence and relationship among symptom. Bri. J. Urol, 1994; 74 : 542 – 550.
- Symptomatologie du bas appareil urinaire de l’homme Fouda et al
- __________________________________________________________________________________
- Health Sci. Dis: Vol 14 [3] September 2013
- 17. Smilié M, Barré C, BEV ZEBOC P, Chautard D, Cornud F, Eschwege P, Fontaine E, Molinie V, Moreau J. C, Meseau M, Ravery V, Mébillard X, Richard P, Ruffion A, Salomon L, Staerman F, Villers A : Cancer de la prostate : Recommandations book en once urologie. Prog. Urol. 2004 ; A suppl. No1, 913 – 942.
- 18. Vela – Navarette R, Alfaro V, Badieka L. L, Fesmandz – Harnando N: Age stratify analysis of I-PSS and Qo1 values in Spanish with symptoms protentially related to BPH Eur. Urol, 200; 38 : 199 –207
References
Guess N. A, Benign prostatic hyperplasia: antecedents and natural history. Epidemiol. Rev, 1992: 14, 131.
2. Barry M. J, Boyle , Garraway W. M, Fang –Liu G, Guess H. A, O’Leary M. P, Ohishi K. and Tsukamoto T; Epidemiology and natural history of BPH. In: Proceedings of the 2nd International consultation in Benign Prostatic Hyperplasia (BPH). Edited by A.T.K. Cockett, S. Khoury, Y. Aso, C. Chatelain, L. Denis, K. Griffitho and G.P. Murphy. Scientific Communication International Ltd, 1993 : pp 19-28.
3. Flam T, Montauban V. Groupe Epimix ; Dépistage de l’hypertrophie bénigne de la prostate clinique en médicine générale : Enquête sur 18540 hommes Prog Urol, 2003 ; 13 : 416 – 424.
4. Girman C. J: Population based studies of the epidemology of benign prostatic hyperplasia. Br. J. Urol, 1994; 74: 542 –550.
5. Tsukamoto T, Kumamoto Y, Masumou N, Guess H. A., Jacobsen J. Steven and Lieber M. M., Prevalence of prostatism in Japanese in community – based study with comparism to similar America study. J. Urol, 1995; 154: 391 – 395.
6. Berry S. J, Coffey D. S, Walsh D. C, Ewing L. L: The development of human benign prostatic hyperplasia with age, J. Urol, 1984; 132: 474 –479.
7. Sagnier P. P. Richard F, Botto H, Teillac P, Boyle P: Adaptation et validation en langue française des score International des symptômes de l’Hypertrophie bénigne de la prostate. Prog. Urol, 1994 ; 4 :532 –538.
8. Cesterling J.E : Benign prostatic hyperplasia : a rview of its histogenesis and natural history. Prostate suppl, 1996 ; 6 :67 – 73.
9. Mac Farlone G, Richard F, Botto H, Teillac P, Boyle P: Results of an epidemiologic survey using a modified American Urological Association Symptom index for benign prostatic hyperplasia in France. J. Urol., 1994; 151 : 1266 – 1270.
10. Garaway W.M, Collins G. N, Lee R. J: High prevalence of benign prostatic hypertrophy in the community . Lancer 1991; 338 :469 – 471.
11. Richard F, Luckas B, Jardin A, Iansony, Cheret Meason M, Gange R. J.C, Navratyl H. Résultats d’une enquête épidémiologique mené chez des hommes âge de 50 à 80 ans étudiant les trouble mictionnels qualifi de vie et fonction sexuelle Prog. Urol, 2001 ; 11 : 250 – 283.
12. Garaway W. M, Russel E.B.A.W, Lea R. J., Collino G. B, Hetir M, Roger A. C. N, Simpson R. J: Impart of previously unrecognised benign prostatic hyperplasia on the daily activites of middle – aged and elderly men. Br. J. Gen. Proet, 1993, 43 : 318 –321.
13. Chute C. G, Panser L.A, Girman C. J, Vesterling J.E, Guess H. A, Jacobson S. J, Lieber H. R : The prevalence of prostatism : a population based survey of urinary symptoms. J. Urol, 1993; 150 : 85 -88
14. Berges R. R, Pientka L, Hafner K, Senge T, Jonas V : male lower urinary tract symptoms and related health care seeking in Germany. Eur. Urol, 2001; 39 : 682 –687.
15. Hunter D. J, Beria Unamuno A, Martin – Gordo A, : Prevevalence of urinary symptom and other urological conditions in Spanish men 50 years or older. J. Urol, 1996; 155; 1965 – 1970.
16. Norman R. W, Nickel J. C, Fish D, Pickett S. N, “Prostate related symptoms“ in Canadian men 50 years of age or older. Prevalence and relationship among symptom. Bri. J. Urol, 1994; 74 : 542 – 550.
Symptomatologie du bas appareil urinaire de l’homme Fouda et al
__________________________________________________________________________________
Health Sci. Dis: Vol 14 [3] September 2013
17. Smilié M, Barré C, BEV ZEBOC P, Chautard D, Cornud F, Eschwege P, Fontaine E, Molinie V, Moreau J. C, Meseau M, Ravery V, Mébillard X, Richard P, Ruffion A, Salomon L, Staerman F, Villers A : Cancer de la prostate : Recommandations book en once urologie. Prog. Urol. 2004 ; A suppl. No1, 913 – 942.
18. Vela – Navarette R, Alfaro V, Badieka L. L, Fesmandz – Harnando N: Age stratify analysis of I-PSS and Qo1 values in Spanish with symptoms protentially related to BPH Eur. Urol, 200; 38 : 199 –207